OPPI appoints Bhushan Akshikar as President
Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in India, has appointed Bhushan Akshikar as its President for a term of two years effective 26th September 2024.
Bhushan is a seasoned business leader and has an experience of over 13 years in key leadership roles in GSK across India, Middle East, Russia CIS & Africa region. Before joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson, in local and regional positions in India, South Korea and Belgium.
Speaking on his appointment, Bhushan Akshikar said, “I am excited and humbled to lead OPPI’s vision to collaborate with the Government of India to enhance access with innovation for patients, at such a crucial time for healthcare in our country. Over the years, OPPI’s focus has been on collective action to forge a path towards a more inclusive, innovative, and sustainable healthcare future for our country. I also extend my gratitude to the members of OPPI’s Executive Committee and I look forward to their continued support.”
Welcoming Bhushan as the President, Suresh Pattathil said “It has been my honour to serve as President of OPPI for the past two years, driving forth its vision of ‘Bharat Ke Liye’. As I transition from this role, I am pleased to handover the leadership to my esteemed colleague, Bhushan Akshikar. I am confident that Bhushan will expertly guide OPPI towards new achievements by leveraging his valuable insights, experience, steering the organization in the right direction to enable innovation, research, access and collaborations. I extend my best wishes to him and sincerely hope to witness OPPI reach new heights of success under his leadership.”
Anil Matai, Director General OPPI said, “I would like to extend my heartfelt gratitude to Suresh for his steadfast dedication to advancing OPPI’s vision of enabling a healthier India through innovative solutions. We look forward to his continued guidance. I am thrilled to welcome Bhushan to his new role. His extensive experience and thought leadership in the pharmaceutical industry will be invaluable as OPPI continues to support the nation’s healthcare objectives with a patient-centric approach. Bhushan has consistently been a strong advocate for healthcare transformation in our country. Under his leadership, we are confident to enhance our efforts to optimize patient outcomes by fostering an environment that encourages innovation and growth”.
Read also: OPPI names Anil Matai as Director General
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.